Bysani G K, Kennedy T P, Ky N, Rao N V, Blaze C A, Hoidal J R
Division of Pediatric Critical Care, University of Tennessee, Memphis.
J Clin Invest. 1990 Nov;86(5):1434-41. doi: 10.1172/JCI114859.
Reactive oxygen species are a major cause of damage occurring in ischemic tissue after reperfusion. During reperfusion transitional metals such as iron are required for reactive oxygen species to mediate their major toxic effects. Xanthine oxidase is an important source of reactive oxygen species during ischemia-reperfusion injury, but not in all organs or species. Because cytochrome P-450 enzymes are an important pulmonary source of superoxide anion (O2-.) generation under basal conditions and during hyperoxia, and provide iron catalysts necessary for hydroxyl radical (.OH) formation and propagation of lipid peroxidation, we postulated that cytochrome P-450 might have a potential role in mediating ischemia-reperfusion injury. In this report, we explored the role of cytochrome P-450 enzymes in a rabbit model of reperfusion lung injury. The P-450 inhibitors 8-methoxypsoralen, piperonyl butoxide, and cimetidine markedly decreased lung edema from transvascular fluid flux. Cimetidine prevented the reperfusion-related increase in lung microvascular permeability, as measured by movement of 125I-albumin from the vascular space into lung water and alveolar fluid. P-450 inhibitors also prevented the increase in lung tissue levels of thiobarbituric acid reactive products in the model. P-450 inhibitors did not block enhanced O2-. generation by ischemic reperfused lungs, measured by in vivo reduction of succinylated ferricytochrome c in lung perfusate, but did prevent the increase in non-protein-bound low molecular weight chelates of iron after reperfusion. Thus, cytochrome P-450 enzymes are not likely a major source of enhanced O2-. generation, but serve as an important source of iron in mediating oxidant injury to the rabbit lung during reperfusion. These results suggest an important role of cytochrome P-450 in reperfusion injury to the lung and suggest potential new therapies for the disorder.
活性氧是再灌注后缺血组织中发生损伤的主要原因。在再灌注期间,诸如铁等过渡金属是活性氧介导其主要毒性作用所必需的。黄嘌呤氧化酶是缺血-再灌注损伤期间活性氧的重要来源,但并非在所有器官或物种中都是如此。由于细胞色素P-450酶在基础条件下和高氧期间是肺中超氧阴离子(O2-.)生成的重要来源,并提供了羟基自由基(.OH)形成和脂质过氧化传播所需的铁催化剂,我们推测细胞色素P-450可能在介导缺血-再灌注损伤中发挥潜在作用。在本报告中,我们探讨了细胞色素P-450酶在兔再灌注肺损伤模型中的作用。P-450抑制剂8-甲氧基补骨脂素、胡椒基丁醚和西咪替丁显著减少了经血管液体通量引起的肺水肿。西咪替丁可防止再灌注相关的肺微血管通透性增加,这通过125I-白蛋白从血管间隙进入肺水和肺泡液的移动来测量。P-450抑制剂还可防止该模型中肺组织硫代巴比妥酸反应产物水平的升高。P-450抑制剂并未阻止缺血再灌注肺增强的O2-.生成,这通过肺灌注液中琥珀酰化铁细胞色素c的体内还原测量,但确实防止了再灌注后非蛋白结合的低分子量铁螯合物的增加。因此,细胞色素P-450酶不太可能是增强的O2-.生成的主要来源,但在介导再灌注期间对兔肺的氧化损伤中作为铁的重要来源。这些结果表明细胞色素P-450在肺再灌注损伤中起重要作用,并提示了该疾病潜在的新疗法。